CHMI(CHMI)
CHMI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $42M | $46M |
| Low | $40M | $44M |
| High | $45M | $49M |
| EBITDA Avg | $23M | $26M |
| Low | $22M | $24M |
| High | $25M | $27M |
| EBIT Avg | $21M | $23M |
| Low | $19M | $21M |
| High | $22M | $24M |
| Net Income Avg | $19M | $22M |
| Low | $18M | $20M |
| High | $21M | $23M |
| EPS Avg | $0.54 | $0.60 |
| Low | $0.49 | $0.55 |
| High | $0.58 | $0.65 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $12M | $11M | $5M | $13M | $11M | $13M |
| Low | $12M | $11M | $5M | $13M | $11M | $13M |
| High | $12M | $11M | $5M | $13M | $11M | $13M |
| EBITDA Avg | $7M | $6M | $3M | $7M | $6M | $7M |
| Low | $7M | $6M | $3M | $7M | $6M | $7M |
| High | $7M | $6M | $3M | $7M | $6M | $7M |
| EBIT Avg | $6M | $6M | $2M | $6M | $5M | $6M |
| Low | $6M | $6M | $2M | $6M | $5M | $6M |
| High | $6M | $6M | $2M | $6M | $5M | $6M |
| Net Income Avg | $5M | $5M | $5M | $5M | $5M | $5M |
| Low | $5M | $5M | $5M | $5M | $5M | $5M |
| High | $5M | $5M | $5M | $5M | $5M | $5M |
| EPS Avg | $0.14 | $0.14 | $0.14 | $0.15 | $0.15 | $0.15 |
| Low | $0.14 | $0.14 | $0.14 | $0.15 | $0.15 | $0.15 |
| High | $0.14 | $0.14 | $0.14 | $0.15 | $0.15 | $0.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |